XML 17 R6.htm IDEA: XBRL DOCUMENT v3.25.0.1
Condensed Statements of Cash Flows (Unaudited) - USD ($)
 3 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Operating activities    
Net income (loss) $ 1,785,322 $ (3,344,900)
Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities:    
Amortization and depreciation 65,127 58,657
Amortization of deferred offering costs 192,647
Debt termination costs reclassed to financing activities 132,091
Stock-based compensation 339,224 308,638
Fair value change in warrant liability (389,445)
Non-cash lease expense 27,537 28,861
Change in assets and liabilities:    
Accounts receivable (2,192,277) (543,399)
Inventory 704,292 118,029
Prepaid expenses and other assets 21,762 3,780
Accounts payable (14,939) 79,527
Accrued expenses, operating leases and other liabilities (463,292) (518,584)
Net cash provided by (used in) operating activities 208,049 (3,809,391)
Investing activities    
Purchase of property and equipment (24,416) (37,131)
Net cash used in investing activities (24,416) (37,131)
Financing activities    
Proceeds from issuance of common stock attributed to equity financings 1,256,271
Issuance costs attributed to common stock and warrants issued in private placements (185,902) (37,698)
Financing costs in connection with debt facility (290,851)
Deferred issuance costs in connection with at-the-market offering program (21,305)
Share repurchases for the payment of employee taxes (11,267) (13,559)
Net cash (used in) provided by financing activities (509,325) 1,205,014
Net decrease in cash (325,692) (2,641,508)
Cash at beginning of period 1,460,042 5,322,493
Cash at end of period 1,134,350 2,680,985
Supplemental non-cash financing and investing transactions:    
Unpaid deferred offering costs attributed to the at-the-market offering program 41,657
Unpaid debt issuance costs 7,091
Modification of right-of-use asset and associated lease liability $ 111,898